Followers | 62 |
Posts | 9561 |
Boards Moderated | 0 |
Alias Born | 03/29/2015 |
Saturday, December 23, 2023 6:34:41 PM
The harm is that when one takes one’s shares out of a brokerage selling them becomes more cumbersome, and cannot necessarily be done on a dime.
Illiquid investments are undesirable compared to liquid ones, all things being equal. Whether it’s a a big harm depends upon whether one ever needs to sell quickly (as nearly happened to prominent NWBO enthusiast some months ago).
True believers in the tech like myself might well stick through to BO or BK and if we decide to sell some after a huge and permanent rise it could be done in days or weeks without being an issue.
The problem is that we need NEW investors to get our SP out of the sewer system.
Convinving new investors that any shares they just bought or might buy might be counterfeit and that they had better make their NWBO investment illiquid just to ensure that they have real shares is an idea likely to scare folks off. If folks want to buy an investment that could be fake they’ll just stay in crypto so we want to avoid making them think NWBO is that kind of Wild West stuff when it’s not.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM